| Mitchell H Bamberger, MD | |
|
50 Memorial Dr Ste 108, Leominster, MA 01453-2238 | |
| (978) 466-2280 | |
| (978) 466-2282 |
| Full Name | Mitchell H Bamberger |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 42 Years |
| Location | 50 Memorial Dr Ste 108, Leominster, Massachusetts |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235108374 | NPI | - | NPPES |
| 110061342A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 71104 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Nashoba Valley Medical Center | Ayer, MA | Hospital |
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
Umeå University in Sweden is leading a team of researchers across Europe in the development of a coronavirus simulation framework that can support decision makers to experiment and evaluate possible interventions and their combined effects, in a simulated controlled world.
While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis. Now, based on the largest cohort of women with fertility problems compiled to date, Danish investigators have shown that women who remained childless after their first investigation for infertility had more hospitalisations for psychiatric disorders than women who had at least one child following their investigation.
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.
Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive data mining, workflow, and reporting features, enabling biopharma and diagnostics companies to leverage the increasing amount of data generated by advanced omics technologies such as next-generation sequencing.
› Verified 9 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
Umeå University in Sweden is leading a team of researchers across Europe in the development of a coronavirus simulation framework that can support decision makers to experiment and evaluate possible interventions and their combined effects, in a simulated controlled world.
While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis. Now, based on the largest cohort of women with fertility problems compiled to date, Danish investigators have shown that women who remained childless after their first investigation for infertility had more hospitalisations for psychiatric disorders than women who had at least one child following their investigation.
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.
Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive data mining, workflow, and reporting features, enabling biopharma and diagnostics companies to leverage the increasing amount of data generated by advanced omics technologies such as next-generation sequencing.
› Verified 9 days ago
| Entity Name | Bamberger Consulting Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497368732 PECOS PAC ID: 6305252370 Enrollment ID: O20210317001569 |
News Archive
Umeå University in Sweden is leading a team of researchers across Europe in the development of a coronavirus simulation framework that can support decision makers to experiment and evaluate possible interventions and their combined effects, in a simulated controlled world.
While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis. Now, based on the largest cohort of women with fertility problems compiled to date, Danish investigators have shown that women who remained childless after their first investigation for infertility had more hospitalisations for psychiatric disorders than women who had at least one child following their investigation.
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.
Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive data mining, workflow, and reporting features, enabling biopharma and diagnostics companies to leverage the increasing amount of data generated by advanced omics technologies such as next-generation sequencing.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell H Bamberger, MD 33 Carriage Hill Cir, Southborough, MA 01772-1341 Ph: (508) 954-9988 | Mitchell H Bamberger, MD 50 Memorial Dr Ste 108, Leominster, MA 01453-2238 Ph: (978) 466-2280 |
News Archive
Umeå University in Sweden is leading a team of researchers across Europe in the development of a coronavirus simulation framework that can support decision makers to experiment and evaluate possible interventions and their combined effects, in a simulated controlled world.
While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis. Now, based on the largest cohort of women with fertility problems compiled to date, Danish investigators have shown that women who remained childless after their first investigation for infertility had more hospitalisations for psychiatric disorders than women who had at least one child following their investigation.
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.
Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive data mining, workflow, and reporting features, enabling biopharma and diagnostics companies to leverage the increasing amount of data generated by advanced omics technologies such as next-generation sequencing.
› Verified 9 days ago
Dr. Stefan G Karos, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Suite 104, Leominster, MA 01453 Phone: 978-466-4075 | |
Ronald G Ebb, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Drive, Suite 108, Leominster, MA 01453 Phone: 978-466-2280 Fax: 978-466-2282 |